Gensia Pharmaceuticals Inc. announced Friday that it haspurchased real estate in San Diego as the site for its corporateheadquarters and centralized research and developmentfacilities.

Gensia paid $10.8 million for the property, which alreadycontains two buildings, but is already in discussions with thirdparties to finance the purchase itself, as well as futureimprovements to the facilities.

Gensia's stock (NASDAQ:GNSA) closed Friday at $22.75 a share,up $1.75.

(c) 1997 American Health Consultants. All rights reserved.

No Comments